Literature DB >> 12654784

Role of antibodies in immunity to Bordetella infections.

Girish S Kirimanjeswara1, Paul B Mann, Eric T Harvill.   

Abstract

The persistence of Bordetella pertussis and B. parapertussis within vaccinated populations and the reemergence of associated disease highlight the need to better understand protective immunity. The present study examined host immunity to bordetellae and addressed potential concerns about the mouse model by using a comparative approach including the closely related mouse pathogen B. bronchiseptica. As previously observed with B. pertussis, all three organisms persisted throughout the respiratory tracts of B-cell-deficient mice, indicating that B cells are required for bacterial clearance. However, adoptively transferred antibodies rapidly cleared B. bronchiseptica but not human pathogens. These results obtained with the mouse model are consistent with human clinical observations, including the lack of correlation between antibody titers and protection, as well as the limited efficacy of intravenous immunoglobulin treatments against human disease. Together, this evidence suggests that the mouse model accurately reflects substantial differences between immunities to these organisms. Although both B. pertussis and B. parapertussis are more closely related to B. bronchiseptica than they are to each other, they share the ability to resist rapid clearance from the lower respiratory tract by adoptively transferred antibodies, an adaptation that correlates with their emergence as human pathogens that circulate within vaccinated populations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654784      PMCID: PMC152104          DOI: 10.1128/IAI.71.4.1719-1724.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Failure of hyperimmune gamma globulin to prevent whooping cough.

Authors:  D MORRIS; J C MCDONALD
Journal:  Arch Dis Child       Date:  1957-06       Impact factor: 3.791

2.  Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

Authors:  M Giuliano; P Mastrantonio; A Giammanco; A Piscitelli; S Salmaso; S G Wassilak
Journal:  J Pediatr       Date:  1998-06       Impact factor: 4.406

3.  Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination.

Authors:  M G Thomas; K Redhead; H P Lambert
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

4.  Molecular evolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences.

Authors:  A van der Zee; F Mooi; J Van Embden; J Musser
Journal:  J Bacteriol       Date:  1997-11       Impact factor: 3.490

5.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

6.  Genetic diversity and relationships in populations of Bordetella spp.

Authors:  J M Musser; E L Hewlett; M S Peppler; R K Selander
Journal:  J Bacteriol       Date:  1986-04       Impact factor: 3.490

7.  Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing.

Authors:  Ulrich Heininger; Peggy A Cotter; Howard W Fescemyer; Guillermo Martinez de Tejada; Ming H Yuk; Jeff F Miller; Eric T Harvill
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

8.  Identification and cloning of waaF (rfaF) from Bordetella pertussis and use to generate mutants of Bordetella spp. with deep rough lipopolysaccharide.

Authors:  A G Allen; T Isobe; D J Maskell
Journal:  J Bacteriol       Date:  1998-01       Impact factor: 3.490

9.  Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production.

Authors:  M Leef; K L Elkins; J Barbic; R D Shahin
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

10.  Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes.

Authors:  B P Mahon; B J Sheahan; F Griffin; G Murphy; K H Mills
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

View more
  59 in total

1.  Humoral immunity against Bordetella pertussis: antibodies or B cells?

Authors:  María Eugenia Rodriguez; W-Ludo van der Pol
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

2.  Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.

Authors:  Nicholas H Carbonetti; Galina V Artamonova; Charlotte Andreasen; Edward Dudley; R Michael Mays; Zoe E V Worthington
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

3.  pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection.

Authors:  Mylisa R Pilione; Elizabeth J Pishko; Andrew Preston; Duncan J Maskell; Eric T Harvill
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

4.  Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.

Authors:  Neelima Sukumar; Gina Parise Sloan; Matt S Conover; Cheraton F Love; Seema Mattoo; Nancy D Kock; Rajendar Deora
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

5.  Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.

Authors:  Girish S Kirimanjeswara; Luis M Agosto; Mary J Kennett; Ottar N Bjornstad; Eric T Harvill
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

6.  Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity.

Authors:  Daniel N Wolfe; Girish S Kirimanjeswara; Eric T Harvill
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance.

Authors:  Mylisa R Pilione; Eric T Harvill
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

8.  CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung.

Authors:  Daniel P Widney; Yan Hu; Amy K Foreman-Wykert; Kim C Bui; Tam T Nguyen; Bao Lu; Craig Gerard; Jeff F Miller; Jeffrey B Smith
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

9.  Evolution of acute infections and the invasion-persistence trade-off.

Authors:  Aaron A King; Sourya Shrestha; Eric T Harvill; Ottar N Bjørnstad
Journal:  Am Nat       Date:  2009-04       Impact factor: 3.926

10.  Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract.

Authors:  Kelly D Elder; Eric T Harvill
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.